# Neurophysiological and Acute Pharmacological Studies in FXS Patients

> **NCT02998151** · EARLY_PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 29 (actual)

## Conditions studied

- Fragile X Syndrome

## Interventions

- **DRUG:** Acamprosate
- **DRUG:** Lovastatin
- **DRUG:** Minocycline
- **DRUG:** Placebo
- **DRUG:** Baclofen

## Key facts

- **NCT ID:** NCT02998151
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02998151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02998151, "Neurophysiological and Acute Pharmacological Studies in FXS Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02998151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*